For: | Martins LS. Autoimmune diabetes recurrence should be routinely monitored after pancreas transplantation. World J Transplant 2014; 4(3): 183-187 [PMID: 25346891 DOI: 10.5500/wjt.v4.i3.183] |
---|---|
URL: | https://www.wjgnet.com/2220-3230/full/v4/i3/183.htm |
Number | Citing Articles |
1 |
Irit Meivar-Levy, Hila Barash, Sarah Ferber. Pancreatic Islet Biology. Stem Cell Biology and Regenerative Medicine 2016; : 193 doi: 10.1007/978-3-319-45307-1_8
|
2 |
Isa Dietrich, Alessandra Crescenzi, Elezar Chaib, Luiz Augusto Carneiro D’Albuquerque. Trophic effects of adipose derived stem cells on Langerhans islets viability — Review. Transplantation Reviews 2015; 29(3): 121 doi: 10.1016/j.trre.2015.04.006
|
3 |
A. S. Severina, I. I. Larina, A. S Shutovа, M. S. Shamkhalova, I. V. Dmitriev, Aleksey V. Pinchuk, S. V. Arzumanov, M. V. Shestakova. Simultaneous pancreas‐kidney transplantation in type 1 diabetes mellitus. Clinical options. Diabetes mellitus 2020; 23(3): 275 doi: 10.14341/DM12509
|
4 |
Roi Anteby, Aaron Lucander, Piotr J. Bachul, Jordan Pyda, Damian Grybowski, Lindsay Basto, Gabriela S. Generette, Laurencia Perea, Karolina Golab, Ling-jia Wang, Martin Tibudan, Celeste Thomas, John Fung, Piotr Witkowski. Evaluating the Prognostic Value of Islet Autoantibody Monitoring in Islet Transplant Recipients with Long-Standing Type 1 Diabetes Mellitus. Journal of Clinical Medicine 2021; 10(12): 2708 doi: 10.3390/jcm10122708
|
5 |
|
6 |
Claire E. Hilburger, Matthew J. Rosenwasser, Derfogail Delcassian. The type 1 diabetes immune niche: Immunomodulatory biomaterial design considerations for beta cell transplant therapies. Journal of Immunology and Regenerative Medicine 2022; 17: 100063 doi: 10.1016/j.regen.2022.100063
|
7 |
Braulio A. Marfil-Garza, Nerea Cuesta-Gomez, A. M. James Shapiro. Pluripotent Stem Cell Therapy for Diabetes. 2023; : 363 doi: 10.1007/978-3-031-41943-0_16
|